BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26598554)

  • 1. PAK6 targets to cell-cell adhesions through its N-terminus in a Cdc42-dependent manner to drive epithelial colony escape.
    Morse EM; Sun X; Olberding JR; Ha BH; Boggon TJ; Calderwood DA
    J Cell Sci; 2016 Jan; 129(2):380-93. PubMed ID: 26598554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The subcellular localization of type I p21-activated kinases is controlled by the disordered variable region and polybasic sequences.
    Sun X; Su VL; Calderwood DA
    J Biol Chem; 2019 Sep; 294(39):14319-14332. PubMed ID: 31391252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and characterization of PAK5, a novel member of mammalian p21-activated kinase-II subfamily that is predominantly expressed in brain.
    Pandey A; Dan I; Kristiansen TZ; Watanabe NM; Voldby J; Kajikawa E; Khosravi-Far R; Blagoev B; Mann M
    Oncogene; 2002 May; 21(24):3939-48. PubMed ID: 12032833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AR and ER interaction with a p21-activated kinase (PAK6).
    Lee SR; Ramos SM; Ko A; Masiello D; Swanson KD; Lu ML; Balk SP
    Mol Endocrinol; 2002 Jan; 16(1):85-99. PubMed ID: 11773441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDC42 binds PAK4 via an extended GTPase-effector interface.
    Ha BH; Boggon TJ
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):531-536. PubMed ID: 29295922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an autoinhibitory domain of p21-activated protein kinase 5.
    Ching YP; Leong VY; Wong CM; Kung HF
    J Biol Chem; 2003 Sep; 278(36):33621-4. PubMed ID: 12860998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pak6 protein kinase is a novel effector of an atypical Rho family GTPase Chp/RhoV.
    Shepelev MV; Korobko IV
    Biochemistry (Mosc); 2012 Jan; 77(1):26-32. PubMed ID: 22339630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A PAK6-IQGAP1 complex promotes disassembly of cell-cell adhesions.
    Fram S; King H; Sacks DB; Wells CM
    Cell Mol Life Sci; 2014 Jul; 71(14):2759-73. PubMed ID: 24352566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of p21-activated kinase 6 by MAP kinase kinase 6 and p38 MAP kinase.
    Kaur R; Liu X; Gjoerup O; Zhang A; Yuan X; Balk SP; Schneider MC; Lu ML
    J Biol Chem; 2005 Feb; 280(5):3323-30. PubMed ID: 15550393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of p21-activated kinase 6-mediated inhibition of androgen receptor signaling.
    Schrantz N; da Silva Correia J; Fowler B; Ge Q; Sun Z; Bokoch GM
    J Biol Chem; 2004 Jan; 279(3):1922-31. PubMed ID: 14573606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate and inhibitor specificity of the type II p21-activated kinase, PAK6.
    Gao J; Ha BH; Lou HJ; Morse EM; Zhang R; Calderwood DA; Turk BE; Boggon TJ
    PLoS One; 2013; 8(10):e77818. PubMed ID: 24204982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutations in the Effector Domain of RhoV GTPase Impair Its Binding to Pak1 Protein Kinase].
    Korobko IV; Shepelev MV
    Mol Biol (Mosk); 2018; 52(4):692-698. PubMed ID: 30113035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delineation of the Cdc42/Rac-binding domain of p21-activated kinase.
    Thompson G; Owen D; Chalk PA; Lowe PN
    Biochemistry; 1998 May; 37(21):7885-91. PubMed ID: 9601050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling, Regulation, and Specificity of the Type II p21-activated Kinases.
    Ha BH; Morse EM; Turk BE; Boggon TJ
    J Biol Chem; 2015 May; 290(21):12975-83. PubMed ID: 25855792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6.
    Yang F; Li X; Sharma M; Zarnegar M; Lim B; Sun Z
    J Biol Chem; 2001 May; 276(18):15345-53. PubMed ID: 11278661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.
    McCarty SK; Saji M; Zhang X; Jarjoura D; Fusco A; Vasko VV; Ringel MD
    Endocr Relat Cancer; 2010 Dec; 17(4):989-99. PubMed ID: 20817787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p21-activated kinases: three more join the Pak.
    Jaffer ZM; Chernoff J
    Int J Biochem Cell Biol; 2002 Jul; 34(7):713-7. PubMed ID: 11950587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a novel mechanism of the PAK1 interaction with the Rho-GTPases Cdc42 and Rac.
    Shin YJ; Kim EH; Roy A; Kim JH
    PLoS One; 2013; 8(8):e71495. PubMed ID: 23936510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAK signaling in cancer.
    Ye DZ; Field J
    Cell Logist; 2012 Apr; 2(2):105-116. PubMed ID: 23162742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of the Pak5 and Pak6 genes in mice leads to deficits in learning and locomotion.
    Nekrasova T; Jobes ML; Ting JH; Wagner GC; Minden A
    Dev Biol; 2008 Oct; 322(1):95-108. PubMed ID: 18675265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.